Pitavastatin Yarindo Mechanism of Action

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Action

Pharmacology: Mechanism of Action: Pitavastatin competitively inhibits HMG-CoA reductase, an enzyme involved in the biosynthesis of cholesterol, thereby reducing cholesterol synthesis in the liver. As a result, there is an upregulation of LDL receptors, leading to increased uptake of LDL from the blood into the liver and a subsequent decrease in plasma total cholesterol (TC). Continued inhibition of hepatic cholesterol synthesis also reduces very low-density lipoprotein (VLDL) levels.

Pitavastatin Yarindo Mechanism of Action

pitavastatin

Manufacturer:

Yarindo Farmatama